Skip to main content

Table 2 PTV dose-constraints and indexes for each patient

From: Contribution of three-dimensional conformal intensity-modulated radiation therapy for women affected by bulky stage II supradiaphragmatic Hodgkin disease

Patient V95% D98% D50% D2% CI HI CO
3D-CRT IMRT HT 3D-CRT IMRT HT 3D-CRT IMRT HT 3D-CRT IMRT HT 3D-CRT IMRT HT 3D-CRT IMRT HT 3D-CRT IMRT HT
1 95.6 96.2 91.3 93.05 102 99.9 106.6 104.1 2.3 1.2 1.1 1.1 0.6 0.8
2 96.8 94,9 92.9 90.7 100.7 99.9 104.7 102.8 2.4 1.1 1.1 1.1 0.7 0.8
3 92.3 98.1 82.5 95.2 100 100 104.4 103.05 2.3 1.3 1.1 1.1 0.5 0.7
4 94.3 99.4 92.3 97.8 99.4 100.1 107.3 102.1 2.8 1.3 1.1 1.1 0.8 0.9
5 91.9 97.5 90.4 94.4 99.1 99.8 105 102.3 2.3 1.3 1.1 1.1 0.6 0.7
6 76.8 94.6 86.3 90.6 97.7 101.2 104.7 105.8 2.6 1.3 1.1 1.1 0.4 0.7
7 94.5 95.3 88.1 92.3 103.05 100 106 101.6 2.8 1.1 1.2 1.1 0.6 0.8
8 92.2 94.9 87.5 91.1 101.6 100 108.6 102.9 2.4 1.1 1.1 1.1 0.5 0.7
9 96.1 94.3 93.3 90.5 99.6 99.7 103.7 102.9 2.4 1.1 1.1 1.1 0.6 0.8
10 94.1 96.8 90.8 93 99.8 99.7 104.5 102.5 2.3 1.3 1.1 1.1 0.7 0.7
11 97.8 94.1 94.6 90 101.7 99.8 104.9 103 3.1 1.1 1.1 1.1 0.5 0.7
12 97.2 95.1 93.7 91.6 102 100 106.6 103.4 3.0 1.1 1.1 1.1 0.8 0.8
13 97.7 94.5 94.5 90.5 101.4 99.8 105.4 102.9 3.0 1.2 1.1 1.1 0.8 0.8
mean 93.7 95.8 90.6 92.4 100.6 100 105.6 103 2.6 1.2 1.1 1.1 0.6 0.8
median 94.5 95.1 91.3 91.6 100.7 99.9 105 102.9 2.4 1.2 1.1 1.1 0.6 0.8
(p) NS NS NS 0.002 0.001 NS 0.001